Company / Return on Assets (ROA)
enGene Holdings Inc. Return on Assets (ROA) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-53.0%
FY2025
5-year range
-114.9% / -17.7%
FY2022-FY2025
Trend
-198.9%
vs FY2024
Sector context
#181 of 213
Health Care
What the data says
enGene Holdings Inc.'s return on assets (roa) of -53.0% is lower than 85% of companies in the Health Care sector (FY2025). Improved from -114.9% to -53.0% over the past 2 years.
Based on SEC 10-K filings.
-53.0% in FY2025 with a 3-year CAGR of +49.3%.
Improved from -114.9% to -53.0% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +49.3pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 213This company -53.0% Sector average -24.1%
▼
-119.3% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 198.9% year-over-year.
- Currently 28.8pp below the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -53.0% | -198.9% |
| FY2024 | -17.7% | +84.6% |
| FY2023 | -114.9% | -12.3% |
| FY2022 | -102.3% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026